Skip to main content
https://www.highperformancecpmgate.com/rgeesizw1?key=a9d7b2ab045c91688419e8e18a006621

Sinovac’s COVID-19 vaccine highly effective against serious illness: study

Sinovac’s COVID-19 vaccine is highly effective against serious illness, although rival shots from Pfizer/BioNTech and AstraZeneca showed better protection rates, a large real world study from Malaysia showed.

The latest data is a boost to the Chinese firm, whose COVID-19 vaccine has been under growing scrutiny over its effectiveness following reports of infections among healthcare workers fully immunized with the Sinovac shot in Indonesia and Thailand.

The study, conducted by the Malaysian government, found that 0.011% of about 7.2 million recipients of the Sinovac shot required treatment in intensive care units (ICU) for COVID-19 infections, health officials told reporters on Thursday.

By contrast, 0.002% of about 6.5 million recipients of the Pfizer/BioNTech vaccine needed ICU treatment for COVID-19 infections, while 0.001% of 744,958 recipients of the AstraZeneca shot required similar treatment.

Kalaiarasu Peariasamy, a director at the Institute for Clinical Research that conducted the study along with a national COVID-19 taskforce, said vaccinations – regardless of the brand – have reduced the risk of admission to intensive care by 83% and lowered the risk of death by 88% based on a smaller study involving about 1.26 million people.

“The breakthrough rate for intensive care unit admission is extremely low,” he said, adding overall ICU admissions among fully vaccinated individuals stood at 0.0066%.

Mortality rate of the fully vaccinated people was also low at 0.01% and the majority of them were either above 60 years of age or with comorbidities.

There were differences in the demographics of the recipients of the three vaccines and it could have resulted in the different results, Kalaiarasu said.

Many of AstraZeneca recipients were in the “mid-adulthood age”, while the Pfizer and Sinovac shots were “very much for the vulnerable population,” he said.

AstraZeneca recipients also accounted for a much smaller proportion of the study, which involved about 14.5 million fully vaccinated individuals and conducted for more than five months since April 1.

In July, Malaysia said it will stop administering the Sinovac vaccine once its supplies end, as it has a sufficient number of other vaccines for its programme.

The Sinovac vaccine has been widely used in several countries including China, Indonesia, Thailand and Brazil, and the company said earlier this month it had supplied 1.8 billion doses at home and abroad.

Malaysia has fully vaccinated 58.7% of its 32 million population and gave at least one dose to 68.8%.

The post Sinovac’s COVID-19 vaccine highly effective against serious illness: study appeared first on ARY NEWS.



from ScienceTechnology – ARY NEWS https://ift.tt/3CGc9Rj https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Uber co-founder Garrett Camp steps back from board director role

Uber co-founder Garrett Camp is relinquishing his role as a board director and switching to board observer — where he says he’ll focus on product strategy for the ride hailing giant. Camp made the announcement in a short Medium post in which he writes of his decade at Uber: “I’ve learned a lot, and realized that I’m most helpful when focused on product strategy & design, and this is where I’d like to focus going forward.” “I will continue to work with Dara [Khosrowshahi, Uber CEO] and the product and technology leadership teams to brainstorm new ideas, iterate on plans and designs, and continue to innovate at scale,” he adds. “We have a strong and diverse team in place, and I’m confident everyone will navigate well during these turbulent times.” The Canadian billionaire entrepreneur signs off by saying he’s looking forward to helping Uber “brainstorm the next big idea”. Camp hasn’t been short of ideas over his career in tech. He’s the co-founder of the web 2.0 recommendatio...

Leading VCs discuss how COVID-19 has impacted the world of digital health

In December 2019, Extra Crunch spoke to a group of investors leading the charge in health tech to discuss where they saw the most opportunity in the space leading into 2020 . At the time, respondents highlighted startups in digital therapeutics, telehealth and mental health that were improving medical practitioner efficiency or streamlining the distribution of care, amongst a variety of other digital health markets that were garnering the most attention. Where top VCs are investing in digital health In the months since, the COVID-19 crisis has debilitated national healthcare systems and the global economy. Weaknesses in healthcare systems have become clearer than ever, while startups and capital providers have struggled to operate while wide swaths of the market effectively shut down. Given significant volatility and the rapid changes seen in the worlds of healthcare, venture and startups broadly, we wanted to understand which inefficiencies might have been brought to light, w...

News-reading app Flipboard expands local coverage, including coronavirus updates, to 12 more U.S. metros

Earlier this year, personalized news aggregation app Flipboard expanded into local news . The feature brought local news, sports, real estate, weather, transportation news and more to 23 cities across the U.S. Today, Flipboard is bringing local news to 12 more U.S. metros and is adding critical coronavirus local coverage to all of the 35 supported locales. The 12 new metros include the following:  Baltimore, Charlotte, Cleveland, Detroit, Indianapolis, Nashville, Pittsburgh, Orlando, Raleigh, Salt Lake City, St. Louis, and Tampa Bay. They join the 23 cities that were already supported:  Atlanta, Austin, Boston, Chicago, Dallas, Denver, Houston, Las Vegas, Los Angeles, Miami, Minneapolis-St. Paul, New Orleans, New York City, Philadelphia, Phoenix, Portland, Sacramento, San Diego, San Francisco Bay Area, Seattle, Toronto, Vancouver and Washington, D.C. To offer local news in its app, Flipboard works with area partners, big and small, like The Plain Dealer’s Cleveland.com , ...